Skip to Main Navigation
Skip to Page Content
Share This:

Scientific Review of Chlorozotocin (CZT)

CASRN 54749-90-5
Status: Listed in the Report on Carcinogens (RoC)

Primary Uses or Exposures: Chlorozotocin (CZT) is a cytostatic agent that is used in the investigational treatment of cancers of the stomach, large intestine, pancreas, and lung, melanoma, and multiple myeloma.

Background Document

No Public Comments


Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, email us or use our contact form and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.